[EN] COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE MALADIES LIÉES À L'OXALATE
申请人:OXALURX INC
公开号:WO2019165159A1
公开(公告)日:2019-08-29
Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject is also provided.
An acetatopalladium(II) complex with 1‐benzyl‐
<i>N</i>
‐(3,5‐di‐
<i>tert</i>
‐butylsalicylidene)piperidin‐4‐amine: Synthesis, structure and catalytic applications in Suzuki–Miyaura coupling of arylboronic acids with hydroxyaryl halides
作者:Srinivas Keesara、G. Narendra Babu、Samudranil Pal
DOI:10.1002/aoc.3778
日期:2017.11
L− and the monodenate OAc− provide a distorted square‐planar N2O2 coordination environment around the metal centre. The physicochemical properties and the spectroscopic features of [Pd(L)(OAc)] are consistent with its molecularstructure. The complex was found to be an effective catalyst for the Suzuki–Miyaura cross‐coupling reactions of hydroxyaryl halides with arylboronic acids in predominantly aqueous
合成了具有式[Pd(L)(OAc)]的席夫碱1-苄基N-(3,5-二叔丁基水杨基)哌啶-4-胺(HL)及其乙酰钯(II)配合物。HL和[Pd(L)(OAc)]均使用元素分析和各种光谱法(红外,紫外可见,1 H NMR和13 C NMR)和质谱测量进行了表征。使用X射线晶体学分析确定复合物的分子结构。在复合物中,钳状NNO供体大号-和monodenate OAC -提供一个扭曲的正方形平面Ñ 2 ö 2金属中心周围的协调环境。[Pd(L)(OAc)]的理化性质和光谱特征与其分子结构一致。发现该络合物是主要在水性介质中的羟基芳基卤化物与芳基硼酸的Suzuki-Miyaura交叉偶联反应的有效催化剂。该反应以宽的底物范围提供了良好至优异产率的羟基联芳基产物。
Palladium-catalyzed direct arylation of phenols with aryl iodides
An efficient protocol of palladium-catalyzed direct para-arylation of unfunctionalized phenols with aryl iodides under mild conditions was reported.
一种高效的钯催化直接对未官能化酚进行芳基碘化的方法在温和条件下被报道。
Compounds and methods for treating oxalate-related diseases
申请人:OxaluRx, Inc.
公开号:US11389456B2
公开(公告)日:2022-07-19
Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject is also provided.
ERβ Ligands. Part 1: The discovery of ERβ selective ligands which embrace the 4-hydroxy-biphenyl template
作者:R Edsall
DOI:10.1016/s0968-0896(03)00303-1
日期:2003.8.5
The synthesis and structure-activity relationships of a series of simple biphenyls is described. Optimization of the 4-hydroxy-biphenyl template led to compounds with ERP selectivity on the order of 20-70-fold. (C) 2003 Elsevier Ltd. All rights reserved.